Exela Pharma Sciences, LLC
Exela develops and manufactures both innovative and generic injectable, ophthalmic and inhalation pharmaceutical products. Exela (Galexe) is located in Lenoir, NC and operates a sterile manufacturing facility. Exela Pharma Sciences (Galexe) is a wholly owned subsidiary of Exela PharmSci, Inc., Reston, Virginia. Our goal is to provide safe and effective pharmaceutical products ensuring compliance with cGMP and other FDA regulations.
ANALYTICAL
API Type


  • Cytotoxic
  • High Potency Drug
  • Small Molecule
Sample Type


  • Dosage form
  • Raw Material
Service Type


  • Methods
    • Method Development
    • Method Validation
  • Test - Release
    • In-vitro release testing
    • Lot and Batch Release Testing
  • Tests - Impurities/Degradation
  • Tests - Stability
  • Tests/Analysis - Other


FORMULATION/MANUFACTURING
API/Business Sector Types


  • Cytotoxic
  • High Potency
  • Small Molecule
Development Stage


  • Formulation
    • Formulation Development
  • Manufacturing
    • GMP Clinical (Phase 1/2)
    • GMP Commercial
    • ICH Batches
    • Scale up
    • Validation Batches
  • Process Development
Formulation Type


  • Inhalation
  • Injectable
    • Injectable Lyophilized
    • Injectable Solution
  • Ophthalmic


MICROBIOLOGICAL TESTING
Development Phase Micro


  • Clinical
  • Commercial mfg
Formulations Serviced


  • Cytotoxic Formulations
  • Inhalation
  • Injectable
  • Opthalmic
Microbiology Services


  • Bacterial Endotoxin Testing
  • Filter Validation
  • Microbial Identification
  • Sterility Testing
  • Sterilization Validations
  • Water Testing (USP)


PACKAGING/FILLING/LABELING
Development Stage


  • Clinical
  • Commercial mfg
Packaging Filling Services


  • Aseptic/Sterile Fill
  • Filling Services
    • Eye Drops
    • Vials


Warning

Close